Company name
LIDE Biotech
Company profile
LIDE Biotech is a preclinical oncology CRO dedicated to advancing translational medical research. Our core offering are preclinical in-vitro and in-vivo assays for IND-enabling drug evaluation studies. We over 200 CDX and 2300 PDX models across 40+ cancer types, with many naturally drug-resistant. Our proprietary 7-day in-vivo assays MiniPDX and IOFIVE offer fast in-vivo validation. Founded in 2011, we operate world-class, AAALAC-accredited SPF animal centers and BSL-2 labs.
Date, time and room information
Tuesday, May 5, 16:00 - 16:15, room Sydney
Category
Commercial stage company
Title of the presentation
Advancing ADC Development: Leveraging AI and Translational Preclinical Models
Speaker information
| Name | Position | Institution |
|---|---|---|
| Simon Jiang | VP of Strategy, Head of Scientific Engagement |
Further information for the sponsor website
